Evidence map›Paper›PMID 35611782›Full record

ReviewCurrent cardiology reviews2023

Malthusian Trajectory for Heart Failure and Novel Translational Ambulatory Technologies.

Bidargaddi Niranjan, Maximilian P de Courten, Pupalan Iyngkaran, Malcolm Battersby

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current cardiology reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Bidargaddi NiranjanDigital Health at College of Medicine and Public Health Flinders University & SAHMRI, Adelaide, Australia.
Maximilian P de CourtenMitchell Institute for Education and Health Policy, Victoria University, 300 Queen St, Melbourne, Australia.
Pupalan IyngkaranMitchell Institute, Victoria University, Melbourne, Australia and Werribee Mercy Sub School, School of Medicine Sydney, The University of Notre Dame Australia, Werribee, Australia.
Malcolm BattersbyCollege of Medicine and Public Health, South Australian Health and Medical Research Institute, Southern Adelaide Local Health Network, Mental Health Division, Flinders Medical Centre, Flinders University, Adelaide, Australia.
Flinders University · AUSouth Australian Health and Medical Research Institute · AUThe University of Notre Dame Australia · AUVictoria University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt has been estimated that congestive heart failure (CHF) will reach epidemic proportions and contribute to large unsustainable impacts on health budgets for any cardiovascular condition. Against other major trends in cardiovascular outcomes, readmission and disease burden continue to rise as the demographics shift.

methodsThe rise in heart failure with preserved ejection fraction (HFpEF) among elderly women will present new challenges. Gold standard care delivers sustainable and cost-effective health improvements using organised care programs. When coordinated with large hospitals, this can be replicated universally.

resultsA gradient of outcomes and ambulatory care needs to be shifted from established institutions and shared with clients and community health services, being a sizeable proportion of CHF care.

conclusionIn this review, we explore health technologies as an emerging opportunity to address gaps in CHF management.

Indexed as

Heart FailureAgedFemaleHumansStroke VolumeAmbulatory carecongestive heart failurehealthmalthusian concepttechnologytranslation

Identifiers

PMID35611782
PMCPMC10280992
OpenAlexW4281482894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.